Biblioteca Humberto Rosselli Quijano
Información del autor
Autor René S. Kahn |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaAntipsychotic use is associated with a blunted cortisol stress response / Lotte C. Houtepen en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.1 (Enero)
Título : Antipsychotic use is associated with a blunted cortisol stress response : A study in euthymic bipolar disorder patients and their unaffected siblings Tipo de documento: texto impreso Autores: Lotte C. Houtepen, Autor ; Marco P.M. Boks, Autor ; René S. Kahn, Autor Fecha de publicación: 2021 Artículo en la página: pp. 77-84 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Estrés, PRUEBA, Antipsicóticos, Medicamentos, Hermanos Resumen: There is ample evidence that the acute stress response is altered in schizophrenia and bipolar disorder. However, it is not clear whether such changes are related to the illness, a genetic vulnerability, or is the result of medication that is used in the majority of these patients. Link: ./index.php?lvl=notice_display&id=26847
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 77-84[artículo] Antipsychotic use is associated with a blunted cortisol stress response : A study in euthymic bipolar disorder patients and their unaffected siblings [texto impreso] / Lotte C. Houtepen, Autor ; Marco P.M. Boks, Autor ; René S. Kahn, Autor . - 2021 . - pp. 77-84.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.1 (Enero) . - pp. 77-84
Palabras clave: Trastorno bipolar, Estrés, PRUEBA, Antipsicóticos, Medicamentos, Hermanos Resumen: There is ample evidence that the acute stress response is altered in schizophrenia and bipolar disorder. However, it is not clear whether such changes are related to the illness, a genetic vulnerability, or is the result of medication that is used in the majority of these patients. Link: ./index.php?lvl=notice_display&id=26847
Título : Cognitive enhancing agents in schizophrenia and bipolar disorder Tipo de documento: texto impreso Autores: Annabel Vreeker, Autor ; Annet H. van Bergen, Autor ; René S. Kahn, Autor Fecha de publicación: 2021 Artículo en la página: pp. 969-1002 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Trastorno bipolar, Cognición, Deterioro cognitivo, Farmacología, Desarrollo de fármacos Resumen: Cognitive dysfunction is a core feature of schizophrenia and is also present in bipolar disorder (BD). Whereas decreased intelligence precedes the onset of psychosis in schizophrenia and remains relatively stable thereafter; high intelligence is a risk factor for bipolar illness but cognitive function decreases after onset of symptoms. Link: ./index.php?lvl=notice_display&id=26760
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.7 (Julio) . - pp. 969-1002[artículo] Cognitive enhancing agents in schizophrenia and bipolar disorder [texto impreso] / Annabel Vreeker, Autor ; Annet H. van Bergen, Autor ; René S. Kahn, Autor . - 2021 . - pp. 969-1002.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.7 (Julio) . - pp. 969-1002
Palabras clave: Esquizofrenia, Trastorno bipolar, Cognición, Deterioro cognitivo, Farmacología, Desarrollo de fármacos Resumen: Cognitive dysfunction is a core feature of schizophrenia and is also present in bipolar disorder (BD). Whereas decreased intelligence precedes the onset of psychosis in schizophrenia and remains relatively stable thereafter; high intelligence is a risk factor for bipolar illness but cognitive function decreases after onset of symptoms. Link: ./index.php?lvl=notice_display&id=26760
Título : On the origins of schizophrenia Tipo de documento: texto impreso Autores: René S. Kahn, Autor Fecha de publicación: 2020 Artículo en la página: pp. 291-297 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cerebro, Disfunción cognitiva, Trastornos psicóticos, Esquizofrenia, Psicología esquizofrénica, Comportamiento social. Resumen: What have we accomplished for schizophrenia patients since the introduction of chlorpromazine in 1952 (1)? Have we really made a difference in the outcome of schizophrenia? When we examine objective and clinically meaningful “hard” outcomes, the answer appears to be negative. Link: ./index.php?lvl=notice_display&id=22659
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 4 (Abril) . - pp. 291-297[artículo] On the origins of schizophrenia [texto impreso] / René S. Kahn, Autor . - 2020 . - pp. 291-297.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 4 (Abril) . - pp. 291-297
Palabras clave: Cerebro, Disfunción cognitiva, Trastornos psicóticos, Esquizofrenia, Psicología esquizofrénica, Comportamiento social. Resumen: What have we accomplished for schizophrenia patients since the introduction of chlorpromazine in 1952 (1)? Have we really made a difference in the outcome of schizophrenia? When we examine objective and clinically meaningful “hard” outcomes, the answer appears to be negative. Link: ./index.php?lvl=notice_display&id=22659
Título : The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia Tipo de documento: texto impreso Autores: Floortje E. Scheepers, Autor ; Christine C. Gispen De Wied, Autor ; René S. Kahn, Autor Fecha de publicación: 2023 Artículo en la página: pp. 575-582 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Hormona adrenocorticotrópica, Benzodiazepinas, Hormonas - metabolismo, Piperazinas, Prolactina, Receptor de serotonina 5-HT2C, Esquizofrenia. Resumen: In addition to dopamine, serotonin (5-hydroxytryptamine, 5-HT) has been reported to play an important role in schizophrenia. Besides blocking dopamine, atypical antipsychotics also block 5-HT receptors. The clinical efficacy of the atypical antipsychotic clozapine is associated with the 5-HT antagonistic action of the drug and a high serotonergic tone before treatment. Link: ./index.php?lvl=notice_display&id=31103
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 575-582[artículo] The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia [texto impreso] / Floortje E. Scheepers, Autor ; Christine C. Gispen De Wied, Autor ; René S. Kahn, Autor . - 2023 . - pp. 575-582.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 575-582
Palabras clave: Hormona adrenocorticotrópica, Benzodiazepinas, Hormonas - metabolismo, Piperazinas, Prolactina, Receptor de serotonina 5-HT2C, Esquizofrenia. Resumen: In addition to dopamine, serotonin (5-hydroxytryptamine, 5-HT) has been reported to play an important role in schizophrenia. Besides blocking dopamine, atypical antipsychotics also block 5-HT receptors. The clinical efficacy of the atypical antipsychotic clozapine is associated with the 5-HT antagonistic action of the drug and a high serotonergic tone before treatment. Link: ./index.php?lvl=notice_display&id=31103
